This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk03: Good day, everyone, and welcome to the Moody's Corporation Third Quarter 2022 Earnings Conference Call. At this time, I would like to inform you that this conference is being recorded and that all participants are in a listen-only mode. At the request of the company, we will open the conference up for questions and answers following the presentation. I will now turn the call over to Shivani Kak, Head of Investor Relations. Please go ahead.
spk12: Thank you, and good afternoon, everyone, and thank you for joining us today. I'm Shivani Kalk, Head of Investor Relations. This afternoon and this morning, Moody's released its results for the third quarter of 2022, as well as our revised outlook for full year 2022. The earnings press release and a presentation to accompany this teleconference are both available on our website at ir.moody's.com. During this call, we will also be presenting non-GAAP or adjusted figures, Please refer to the tables at the end of our earnings press release filed this morning for a reconciliation between all adjusted measures referenced during this call in US GAAP. I call your attention to the safe harbor language which can be found towards the end of our earnings release. Today's remarks may contain forward looking statements within the meaning of the Private Securities Litigation Form Act of 1995. In accordance with the Act, I also direct your attention to the management's discussion and analysis section and the risk factors discussed in our annual report on Form 10-K for the year ended December 31st, 2021, and in other SEC filings made by the company, which are available on our website and on the SEC's website. These, together with the safe harbour statement, set forth important factors that could cause actual results to differ materially from those contained in any such forward-looking statements. I would also like to point out that members of the media may be on the call this morning in a listen-only mode. Rob Fauber, Moody's President and Chief Executive Officer, will provide an overview of our results and outlook, after which he'll be joined by Mark Kaye, Moody's Chief Financial Officer, to answer your questions. I will now turn the call over to Rob Fauber.
spk09: Thanks, Shivani. Good afternoon, and thanks to everybody for joining today's call. Like I did Last quarter, I'm going to start with a few takeaways. And as everybody's aware, during the third quarter, macroeconomic and geopolitical conditions continued to deteriorate. And that further suppressed the global debt issuance markets from the already subdued levels that we had seen in the first half of the year. At the same time, these conditions supported increasing customer demand for data and analytics to identify, measure, and manage risk. And against this backdrop, Our MA business continued to perform well, with strong revenue growth of 14%, while MIS revenue declined by 36%. And overall, Moody's generated $1.3 billion in revenue with an adjusted operating margin of 39%. And we expect that low issuance volumes, particularly in the leveraged finance space, will persist through the remainder of the year. And as a result, we're revising several of our 2022 outlook metrics, including our guidance for total Moody's revenue, which is now expected to decline in the low double-digit range. And we're also updating our outlook for full year adjusted diluted EPS to now be between $8.20 and $8.50. Now, in response to the expectation for continued economic headwinds, we're also taking decisive steps to reduce our expense run rate by at least $200 million by year end. And the cost savings will be realized across the company and include a more than doubling in the size of our previously announced restructuring program, as well as various additional cost efficiency initiatives. And collectively, These actions put us in a position of strength as we head into 2023, and I'll provide some additional details later in the call. Now, for the third quarter, MA recorded both strong revenue growth of 14% and a 9% increase in annualized recurring revenue, or ARR. With over half of MA's business outside the U.S., foreign exchange rates had an outsized impact on MA's revenue growth, lowering it by 7 percentage points. For MIS, the 36% decrease in revenue against the record prior year period was driven by a 41% reduction in issuance. And altogether, this resulted in a 16% decline in Moody's revenue. And the negative impact of foreign currency movements on total Moody's revenue was four percentage points. Now, expenses grew just 1% in the third quarter as we continued to execute efficiency initiatives and emphasize cost discipline, and the net impact of lower revenue and controlled expenses translated to adjusted operating income of $497 million for the quarter and adjusted diluted EPS of $1.85. Now, let me provide some additional context on the conditions impacting issuance levels and our revised full-year outlook for MIS. And at the beginning of the year, like others in the market, we anticipated that elevated levels of inflation would be transitory and slowly abate over the course of 2022. And instead, the conflict in Ukraine further impacted market confidence and commodity price shocks pushed inflation higher. And these factors prompted central banks to raise interest rates further and faster than expected. to levels we haven't seen for more than a decade and resulting in ongoing uncertainty and volatility in the capital markets. Meanwhile, corporate balance sheets remained robust following a surge in opportunistic pandemic-era financing, allowing issuers to stay on the sidelines given market conditions. We expect that these macroeconomic and geopolitical conditions will continue to mute issuance levels at least through year-end, And in light of this, we're updating our guidance for 2022 MIS-rated issuance to decline in the mid-30s percent range. Full-year MIS revenue is now projected to decrease by approximately 30%. And while the outlook for next year will depend on the pace and scope of market stabilization and recovery, we're confident that conditions will improve over time and that the key growth drivers for issuance will resume. This year, only a little more than a quarter of the first-time mandates that we've signed have gone to market, meaning there's a backlog waiting to tap the markets. And to leverage those opportunities, our teams have been engaging extensively with investors and issuers. We haven't been sitting still. We've been building our domestic rating franchises, including in Africa with the majority acquisition of GCR and across Latin America through Moody's Local. and we've made significant progress in digitizing our content to both improve the customer experience but also to drive increased usage. As we look ahead, our pricing opportunity remains intact, and we know there are over $4 trillion in refunding needs that will likely be refinanced over the coming four years. In short, we're continuing to deliver on our differentiated strategy to be the agency of choice for our customers. While current conditions for MIS are challenging as those ease, Issuance will accelerate, and we will be well positioned to capture growth and operating leverage through our extensive market presence. Now, turning to MA, which, despite the challenging market conditions, delivered another impressive quarter of revenue growth and margin expansion. Fifty-nine consecutive quarters of revenue growth, MA has proven to be acyclical, and the third quarter was no different. ma reported 14 revenue growth or nine percent on an organic constant currency basis and with best-in-class retention rates and growing customer demand ma also achieved nine percent arr growth for the third quarter and that's inclusive of rms we're confirming our top line revenue guidance for 2022 MA full-year revenue is expected to increase in the mid-teens percent range, and that's despite a 5 percentage point headwind from foreign exchange rates. We expect ARR to accelerate to low double-digit percent growth by year end. We're also raising the MA adjusted margin guidance to approximately 30 percent, and that's a 100 basis point increase over our prior guidance, reflecting ongoing expense efficiency. So let me take a moment just to highlight our fastest-growing business, and that's KYC and compliance solutions. And in recent years, we've invested, and that's been both organically and inorganically, in acquiring, developing, and integrating data, analytics, and technology to create a world-class set of solutions. And this combination supports new use cases around counterparty verification. That's enabling us to grow with existing customers and add new customers in areas like the fintech, corporate, and government sectors. We continue to receive industry awards and recognition, including most recently a top-right quadrant positioning from Chartas. We also won the AI Breakthrough Award for our innovative solution for fraud prevention. And that's one of an increasing number of places where we're being recognized for the integration of artificial intelligence into our solutions. Also, as we pass on the one-year anniversary of the RMS acquisition, let me give a quick update on that. We're on track to achieve the financial targets announced last August, and I'm excited about the opportunities that are in front of us. We are laser-focused on maximizing our synergy opportunities by launching new products and pursuing markets that leverage our combined capabilities and strengths. So, for example, this past quarter, we launched our ESG underwriting solution for property and casualty insurers, which integrates Moody's extensive data to help them operationalize ESG risk assessment into their insurance underwriting workflows. And I also want to recognize the great work being done by our colleagues at RMS. And in my meetings with customers over the last few months, I've heard firsthand about how important our solutions are in helping the industry address an increasing array of risks, including recently as we assisted our customers in rapidly quantifying the financial impact of hurricanes Fiona and Ian. Now, moving to the restructuring plan that I mentioned earlier. On our last earnings call, we said that we would take additional actions to manage expenses and improve operating leverage if we observed further deterioration in the external environment. And given our view that the weakness in the issuance market will likely persist through at least the fourth quarter of 2022, our teams have undertaken a careful review of prioritization of ongoing initiatives, and we've identified several avenues for meaningful savings. We are expanding our restructuring program to more than double providing up to $135 million in savings in 2023 from a combination of rationalizing our real estate footprint and reducing our global workforce to reflect the reality of the current market environment. We have also undertaken a careful prioritization of ongoing initiatives in light of our current business priorities. And that has identified up to $100 million in additional savings. So collectively, these are projected to lower our 2023 expense run rate by at least $200 million. And as we take these decisive actions, we will be mindful to invest and allocate resources to maintain the rigor and quality of our ratings and processes. Look, these are challenging and uncertain times, and we are prioritizing financial discipline today and making sure that we're well positioned to capture growth opportunities tomorrow. So that concludes my prepared remarks, and Mark and I would be pleased to take your questions. Operator.
spk03: Thank you. If you would like to ask a question, please dial star 1 on your telephone keypad. If you are on a speakerphone, please pick up your handset and make sure your mute function is turned off so that your signal reaches our equipment. We will ask that you please limit yourself to one question. You will have a chance to rejoin the queue for a follow-up. Again, that is star 1 to ask a question. And the first question is from the line of Ashish Sabadro with RBC Capital Markets.
spk17: Please go ahead. Thanks for taking my question. I was just wondering if you, as we think into 2023, if you could provide any initial color on how we should think about issuance. There was obviously an expectation that we may see a big bounce back in issuance. Is that still an expectation as we get into 2023? Or just given the higher interest rate, is it more reasonable to think about a gradual recovery? I was just wondering if you could share some initial thoughts. Thanks.
spk09: Hey, Ashish, it's Rob, and I'm pretty sure we're going to get multiple questions around issuance environment and issuance outlook. So maybe let me start with kind of a big picture view, and then as the call progresses, we'll continue to kind of drill down, and I know we'll talk about 2023. But, you know, you've heard me oftentimes on these earnings calls when I said that I thought that the market could absorb rate increases, as long as they were well anticipated by the market and they were accompanied by economic growth and and that's that that is not what we have had this year so the the tightening cycle is really the steepest of the past two decades i think that initially surprised the market uh and it has been accompanied by decelerating economic growth so you know back on the the uh the the the last call i talked about the factors that were causing the disruption to the market at the time And I noted that despite those factors, we expected that at the time, 2022 issuance was going to come in roughly in line with the average of issuance from that 2012 to 19 period that excludes those pandemic years of 2020 and 21. But given the weakness in the third quarter that, as you heard me say, we expect to continue into the fourth quarter, we now think that the overall global issuance is going to be down something like close to 10% from that historical average. But what has really changed is that we now expect corporate issuance, and I'm including investment grade and leveraged finance, to be down almost 30% from that historical average ex-pandemic. So this is no longer kind of just down off of two unusual and record years for issuance, but now we see corporate issuance down meaningfully from its ex-pandemic average going back to 2012. And I think that kind of illustrates the depth of the cyclical contraction that we're dealing with at the moment. And as I think about, you know, for the remainder of the year, I think the key is for the market to be able to get some certainty before it starts to get volatility. I think that's going to be the key. So let me pause there, and I'm sure we're going to have some other issuance questions as we go forward.
spk03: Your next question is from the line of Amanav Pednaik with Barclays. Please go ahead.
spk14: Yeah, maybe I'll follow up as you anticipated there, Rob. You know, you talked about $4 trillion of resign needs over four years. I was hoping you could just, you know, help us how that breaks out. It looks like more of it might be in 2024, but just curious on your numbers. And then, you know, in a typical year, how much is refi as part of the given issue compared to, I guess, you know, the rest of the categories, which might just be more on capital allocation as a group, if that's correct?
spk09: Yeah. So, we included, I think, a slide in the supplemental materials around the maturity walls. And, you know, as you said, you know, it's $4 trillion, $4 to $4.1 trillion, very significant amount of debt that's got to get refinanced over the coming four years across the United States and EMEA. And it's interesting. We actually, as we kind of normalized, you had about $200 billion of debt that fell out of the study due to withdrawing ratings in Russia. So the refi walls actually did actually grow this past year. It grew something like 4% on a like-for-like basis. But I think what's really interesting, Manav, if you go back just, you know, just look at the slides back to 2019, those maturity walls have grown 28% from 2019. But if you actually go back another year, 2018, they're up 54%. And, you know, we're looking at a few things. So, one, just the absolute maturity walls are significant and they continue to grow, despite the fact there was obviously some refinancing activity that was going on when rates were ultra-low. If you look at U.S. spec grade for a moment, so if you look at the first two years in our refunding studies, they're about 18% of the five-year total. That's the highest percentage since we started tracking it in 2010. And the other thing I would say, Manav, just to also try to triangulate to your question, you know, if you look at the maturity walls for 2023, and you look at what our expectation is for corporate issuance for 2022, and I understand that's a little apples to oranges, But it represents about 50% of what we expect to be the global corporate financing activity in 2022. That's a pretty big number. And remember, 40% of the MIS business, thereabouts, is recurring revenue. So now we're talking about the support for that other 60%.
spk03: Our next question is from the line of Alice Cram with UBS. Please go ahead.
spk13: Yeah, hey, good morning, or good afternoon, everyone, rather. I wanted to shift gears to the cost base, understand the restructuring program, but it would be helpful if you, I guess, Mark, flushes out a little bit more. So the $200 million achieved by the end of the year, how much of that is going to be actually impacting this year's full-year cost base and then, I guess, into 2023? How much on a net basis will be incremental as we think about the outlook there? And then more importantly, I guess, if we expect growth to accelerate next year, hopefully, how should we be thinking about incremental margins on the ratings business? And are the low 60s targets median terms still intact? So I know that's a three-part question, but I think it's all important.
spk16: Alex, good afternoon. I anticipate we may get a couple of questions on expenses during our Q&A session today, and so I'll start off maybe by talking broadly about the restructuring program and addressing some of your margin-specific questions now, and certainly we can take further ones later on. So the market disruption and downturn, as you heard from Rob, has extended for longer and has been more severe than what we anticipated earlier in the year. And because we're primarily thinking that this will extend at least through the fourth quarter, we're taking actions consistent with our prior commitments and comments around being financially prudent and expense decisive. And that really means expanding the 2022-2023 geolocation restructuring program that we established last quarter. So specifically, through year-end 2023, we now expect up to $170 million in or an approximate $95 million increase in aggregate charges related to additional real estate rationalization, as well as reduction of staff. And that's going to include further utilization of alternative lower-cost locations where the requisite skills and talents exist. And that's all while ensuring that our focus and resources remain firmly allocated to protecting the high quality of our core ratings business, and continuing to strategically invest in growth areas within both MIS and MA. For the full year 2022, as we take these additional personnel-related actions, as well as exit and cease use of certain leased office space, we plan to record up to approximately $85 million in estimated pre-tax restructuring charges, and that's going to be inclusive of the $33 million pre-tax restructuring charge that we've recorded year-to-date. And that means the remaining portion of the up to $170 million in restructuring charges will be recorded then in 2023. And these actions are now projected to result in an annualized savings in a range of $100 million to $135 million, and that's more than double the $40 million to $60 million annualized savings that we forecast under the restructuring program that we established last quarter. Furthermore, as you heard Rob mention just a minute ago, we have evaluated other opportunities for cost reduction, and that includes adjusting compensation policies, certain salary bands, reducing non-compensation expenses, as well as restating some of our business strategies. And those additional cost reductions, along with this $100 million to $135 million in savings from the upsized restructuring program, that will generate at least that $200 million run rate of savings as we enter into 2023. And we plan to use these savings, to your second part of your question, to really support profitability and business margins as we take action towards achieving our medium-term financial target and, to a lesser extent, plan to redeploy towards strategic investments, including workplace enhancement. And, you know, while we'll provide official guidance for the full year of 2023 in February, these expense actions are anticipated to increase and stabilize MIS's 2023 adjusted operating margin in at least the mid-50s percentage range, and they'll continue to expand MA's adjusted operating margin as well.
spk13: All right. That's a good start. Thank you.
spk03: Your next question is from the line of Kevin McVeigh with Credit Suisse. Please go ahead.
spk18: Great. Thanks so much, and congratulations on that. the proactive expense management. I don't know who this would be for, but can you give us a sense of what level of conservatism you have in the 2022 guidance based on the adjustments you've made kind of year to date?
spk09: Yeah. Hey, Kevin. Thanks for joining us today. You're welcome. sure you know the way we kind of put together the you're talking about the you know the remainder of the guidance for the remainder of the year you know we've essentially assumed a continuation of of what we're seeing right now into into and throughout the fourth quarter um and just to give you a sense um our our revised guidance um for issuance implies that fourth quarter rate of issuance to be down in, I call it kind of a low 40s percent range. And, you know, if we have another quarter of assumed unfavorable mix because of the softness in the leveraged finance markets, that would mean MIS transaction revenues would be down greater than that, right? So they'd be down in the kind of low 50s percent range. And then when you triangulate that back to revenue implies that, you know, fourth quarter MIS revenue would be down in the mid 30s percent range. And so that feels about right to us that we're going to continue with this environment. We've got a pretty muted environment at the moment. um and i i think you know the rest of the year in a way because we're assuming that this continues kind of thinking of it as a bit of a wash because i think we're going to be in a holding pattern until the market can get some more confidence about inflation peaking and in turn the the some certainty around the pace and trajectory of fed rate increases yeah maybe i just briefly had two quick points uh it's worth highlighting that the confident intervals around our modeled outlook
spk16: are wider relative to what we've seen in prior periods, and that's simply reflecting the heightened market uncertainty and volatility that we're currently experiencing. And then, in contrast, AMA has shown significant resilience to the current market disruption, really as our customers continue to elevate and improve their level of risk resiliency, which underscores the mission-critical nature of our products. Thanks so much.
spk03: Your next question is from the line of Tony Kaplan with Morgan Stanley. Please go ahead.
spk10: Thanks so much. I wanted to ask again on the sort of outlook on issuance long term. You highlighted the refunding needs that's supportive. And just wanted to understand if there's anything that you've seen so far that would lead you to think that companies will try to de-lever in the coming years or anything that would sort of change the structural versus cyclical debate. And I know, Rob, you already said that you still think it's cyclical, but just any data points that you're looking at that would maybe influence that decision or debate.
spk09: Yeah, Tony, sure. So we'll kind of zoom out here, and if we need to kind of zoom back into 2023, I'm sure we'll do that. But as you said, Tony, you know, there's some pretty deep cyclical issues at the moment. We've talked about all the macro uncertainty. You know, you've obviously got the market working off some of the excess supply of issuance over the two pandemic years. But, you know, there are a few things I think that we're looking at that we feel are providing some, I would say, structural support for recovery and issuance markets. I talked about the refinancing laws, and those are very significant. You know, there's some concern during the pandemic with ultra-low interest rates that, you know, we were eating into those maturity walls. It turns out they're intact and, in fact, continuing to grow and will provide support for transactional revenue. But I also say, you know, there's been no change to the relative attractiveness of debt financing. And you remember on various calls over the past, we've been talking about potential changes to tax codes and other things. None of that is out there. We've also seen, you know, there's been a lot of focus on cash balances. And certainly U.S. corporates were building cash during the pandemic years. We started to see that come down. So our cash pile report shows about a 7% decrease over the last year. Cash levels are similar to where they were in 2018. And I would also say, Tony, that, you know, I'm going to zoom in on the U.S. for a moment, but U.S. corporates are in pretty good shape from a leverage standpoint. When we look at free cash flow to debt, that's one way to look at it across our rated U.S. corporates. It's at about 11%. That's the best that it's been since 2011. So that to me means that corporates still have some room to take on some additional leverage. And then the last thing maybe I would say is, you know, at the moment we're continuing to see some stability of spreads. kind of remaining around historical averages. You heard me talk about a backlog of FTM. So despite all of this, and maybe that's not a long term, maybe that's a shorter term, but we do have, we are seeing a lot of interest from issuers who want to tap the markets. So as economic growth picks up, we expect all of that to be, you know, positive for issuance. I do think this is, as I said, is mostly cyclical. Cycles, you know, come and go, but we feel good about our leverage to a recovery in the markets.
spk10: Super. Thanks.
spk03: Your next question is from the line of Andrew Nicholas with William Blair. Please go ahead.
spk06: Hi, good afternoon. Thanks for taking my question. I just wanted to clarify a few things on the restructuring program. First, I want to make sure I'm looking at the slide, slide 10. I want to make sure that that incremental savings of up to $100 million on the non-restructuring related expense actions, I want to make sure that that's something that's baked in as opposed to a contingency plan. And then also, if you could give any color, and I apologize if I missed it, In terms of the split of those cost savings between corporate expenses versus MIS versus MA, I think it would be helpful to understand that mid-50s MIS range that you alluded to, Mark, how much of that is a consequence of cost savings versus or cost actions versus maybe some baked-in growth next year. Thank you.
spk16: Good day. Good afternoon. In terms of the incremental savings of up to $100 million that we list on page 10 of the supplemental slide set, those are not contingency-based savings. Those are certainly actions that we will anticipate taking. Maybe, Andrew, let me take your question from the perspective of expense levers that we have in the business, and I'll try to group this in really four primary buckets, and that will give you a feel for how ultimately those savings are going to translate through to the two different segments. The first lever is very much related to our hybrid and purpose-driven work environment. And this environment really enables us to be equally effective and productive as we were pre-pandemic with a much smaller physical office footprint. So last quarter, we announced plans to exit a certain office space. And after further assessing the best use of our real estate footprint, as well as gathering feedback from our global employees on their workplace preferences, We have identified additional opportunities for real estate rationalization as part of that expanded global restructuring program. And that real estate rationalization range that we're looking at is between that $50 to $70 million in total. The second category I'd point you to is certain non-compensation costs like T&E that are primarily business-facing. And those have increased compared to the prior two years. Now, although we anticipated these expenses to rise, there are others that we are prioritizing and reducing through supplier cost avoidances, rebates and volume discounts, as well as negotiating for comparable levels of service with more favorable terms. And that's going to include assessing whether any existing external services can be absorbed into employees' day-to-day responsibilities. Now, the third category is really the largest, and that's our largest expense, and that's people. And approximately 60% of our expense base is compensation and benefits. And we've already taken aggressive actions to prioritize hiring and open positions in key areas. And really, as part of our expanded restructuring program, we plan to increase our utilization of some of the alternative lower-cost locations, again, where those requisite skills and talent exist, but protecting ultimately the high quality of the ratings and continuing to invest. And those actions themselves is really what's going to lead to a higher MIS adjusted operating margin, at least in that mid-50s range that I mentioned earlier. And then fourth and finally, you know, we also have naturally occurring expense levers in the business, for example, our incentive compensation accruals. Those are going to flex based on the actual performance as compared to the financial targets that we set at the start of next year.
spk09: Yeah, just to reinforce, not contingent. Those are actions that we're taking now to make sure that we can realize those savings for full year 2023.
spk03: Great. Thank you. Your next question is from the line of Jeff Silber with BMO Capital Markets, please go ahead.
spk07: Thanks so much. I want to get back to the issuance environment. I'm just curious what you think will be the first sign that issuers are looking for to come back into the market and where in terms of which articles we might see those green shoots. Thanks.
spk09: Yeah, so maybe this is a good time to kind of talk about 2023 and how we see you know, issuance starting to evolve over the, you know, the coming quarters. And I'll touch on what those triggers are as I talk about that. So as we always do, we're going to provide our official forecast and guidance on our fourth quarter earnings call in February. It's just too early, I'm sure, as you can appreciate, given all of the uncertainty. But the first thing, so the first trigger is I think we've got to get some certainty into the market. And I mentioned earlier that means that the market has got to get confidence that inflation is peaking so that the market can then get comfort with the pace and trajectory of Fed rate increases. And that is really, really important. And I don't think we've seen that yet. And so, you know, our view is that Fed funds is going to peak, you know, sometime in the first quarter of 2023. But, you know, the headwinds that we've got now are not just going to disappear overnight. We think that it's going to take into early 2023 to resolve some of that. And we're still going to have a relatively tough issuance comp in the first quarter. And maybe it's worth me just kind of saying, just in terms of where do I think we are in all of this, I think that the third and fourth quarters of this year are really kind of the trough for us in terms of the rate of issuance decline from prior periods. And I think that's going to gradually improve throughout 2023, and particularly in the second half of 2023 when we get some easier comps. So I think we're going to look for that certainty. As I said, what we typically see in terms of the markets opening up, so you see the big investment-grade issuers, you start to see opportunistic investment-grade issuance. and then you see higher-rated leveraged finance issuers starting to tap the market and really start to open the leveraged finance market back up. So we're going to want to have default rates that are under control, spreads that are, as I said, that's why it's important to look at spreads around the historical historical averages, and then we'll start to see that leveraged finance market open up. As I said, we've got a lot of backlog. We've got a lot of first-time mandates that have not tapped the markets, and we know there's a lot of private equity dry powder waiting to get deployed. So that's how I would think about, you know, when we can – what it's going to take to start to kind of unlock the market.
spk07: All right. That was really helpful. Thanks so much.
spk03: Your next question is from the line of George Tong with Goldman Sachs. Please go ahead.
spk04: Hi, thanks. Good afternoon. Sticking with the topic of debt issuance, your guidance implies 4Q issuance will be down in the low 40s range, similar to 3Q. If you look at how 3Q progressed, it did get worse progressively moving through the quarter, and the first couple of weeks of October were quite weak, much, much steeper declines than before. So just curious, what assumptions are you baking into 4Q? Are you assuming the exit rates from 3Q and early 4Q will reverse and get better such that you land at overall average 3Q levels? And if so, what are you seeing in the markets that would prompt that?
spk16: George, good afternoon. This is Mark here. I think your underlying hypothesis and thesis is very consistent with the scenarios that we looked at in setting our guidance for the remainder of the year. We definitely overweighted the September and October month-to-date issuance, informing our outlook for the remainder of the year. However, there really are two key points I want to stress here. One, the bands are wider now, thinking about the outlook for the year, than what we've historically seen. And second, we do believe this disruption is predominantly cyclical in nature. You heard Rob talk about it minutes ago, that we may be at the low point of the cyclical cycle. So while we may see transactional revenue declines in the first half of next year, they're unlikely to be that same level of severity that we've seen in the fourth seen in the third quarter and are implied for the fourth quarter. So those are the kind of things that we're thinking about sort of as we develop the forecast for the year and as we're thinking about the first half of next year.
spk03: Got it. Thank you. Our next question is from the line of Owen Lauf with Oppenheimer. Please go ahead.
spk19: Thank you, and thank you for taking my questions. Could you please talk about how the private credit markets have impacted your results? Is there any area that Moody's can still get a piece of it? And also, how do you think about your ability to achieve your medium-term targets based on current backdrop? Thank you.
spk09: Hey, Owen. Thanks. So this is an interesting topic, and we've been getting some questions from investors about this. So let me share a few perspectives on this. First of all, just kind of the size of the market, about $1.2 trillion in 2021. It's expected to continue to grow, assuming that this asset class continues to hold up. But the segment of market that represents, I think, the potential cannibalization risk Our loans, I'd say $300 million and up. That's kind of broadly the minimum threshold for deals that get done in a public market. And in 2021, something like $50 billion of those loans done in the private credit market versus a leveraged finance market that was, call it, $1.3 trillion. So this year we've had, you know, severe dislocation in the public leveraged finance markets. And that figure for that cohort of loans, you know, could be as high as, you know, kind of 90 to 100 billion. So, you know, yes, the private credit market was able to step in and provide some financing for certain transactions while the public markets were dislocated. But I think that actually brings us to an interesting question about risk and sustainability. So private credit market clearly has more flexibility to provide higher leverage than public markets, meaningfully higher leverage. The cost of private debts is typically higher yielding, right, so more expensive than public markets. And leveraged companies with expensive debt typically have high default rates during periods of stress. I'd be wary of people that tell you that this time or this sector is different. So it remains to be seen how this asset class is going to fare if we've got a meaningful increase in credit stress. I think it's probably going to be hard to get a true apples-to-apples comparison on default rates, given that private lenders may be able to renegotiate agreements in times of credit stress. That growth and that opacity in this market is leading some people to start to call for, you know, regulation. But it's also where I think that growth and opacity is where we can add value. So, you know, first, as I said, you know, given the cost of project debt, I think it's corporate borrowers as their credit profiles improve, you know, I think we're going to see some of these companies want to move from the private credit markets into the public credit markets. So that growth of the private credit markets, I think, does represent some some future first-time issuers into the public markets over time. Second of all, we're actively engaged in outreach in this market to see how we may be able to provide things like private ratings or credit assessments before those companies do, in fact, tap the public markets. And the other thing I'd say is, we're starting to engage with investors in these credit funds who are looking for more transparency as to the credit quality of the funds that they're invested in. And they're saying, hey, rather than the internal risk ratings that these credit funds are using, we want to get an independent assessment of credit risk of the portfolio that we're invested in. So I think we're really well positioned to serve that particular need. We've got our risk calc and EDF credit models that are really considered yeah the gold standard for corporate uh portfolio credit analysis around the world and we're starting to develop a sales pipeline around that so i'll the last thing i'd say is So, yes, private credit has been a meaningful source of leveraged finance funding this year as public markets were challenged. But we are seeing the market dynamics in that market starting to shift a bit as well. I mean, you know, private credit is not immune to what we're seeing in the market. So you see credit funds cutting back on debt packages or increasing the, you know, the equity component of deals or pulling back from big buyouts. So, while we're engaged with private borrowers, private equity, credit funds, and investors to see how we can play a more important role by bringing transparency to this market. So stay tuned.
spk16: Owen, on your second question, just on the medium-term target, so we introduced medium-term guidance in February of this year, and we said 2021 is the base year. And that was obviously prior to the very significant geopolitical shocks that have resulted from the Russia-Ukraine conflict, as well as the unforeseen degree to which inflationary pressures, driven by post-pandemic demand supply mismatches, would emerge. In establishing our medium-term targets, we intentionally assumed a period of economic stress following two historically strong issuance years. Our assumptions included foreign exchange rate stability, as well as the expectation for interest rates to gradually rise over this period, with global GDP gradually decreasing. However, as we know, this is certainly not how 2022 has unfolded in this space. and the degree of macroeconomic headwinds with inflation at levels not experienced in decades. And, you know, as a result, you know, we've seen central banks rapidly rise rates in an attempt to curb inflation expectation, and we've seen FX rates react quite significantly with the flight to quality. And so those factors collectively have contributed to a lot of what we spoke about on the call this morning, really that extended and more severe market disruption. Now, fundamentally, we believe the underlying factors and drivers of our business remain firmly intact. And the key to achieving our medium-term targets is going to be heavily influenced now not only by the macroeconomic outlook, but also efforts around expense, prudence, and discipline. and the issuance recovery pattern that we're going to see in 2023 and beyond as issuers return to the market to refinance those existing obligations, fund their working capital needs, and really invest for growth. And so given those developments, we'll be revising select medium-term guidance metrics when we hold our fourth quarter earnings call in February.
spk19: Thank you very much.
spk03: Your next question is from the line of Pfizer all the way with Deutsche Bank. Please go ahead.
spk01: Yes. Hi. Thank you. So I'm going to sneak into just one is on any margins. I believe you increased your outlook for 22. And I'm curious if that. What's the reason for that? If you're maybe deferring some investments that you were originally planning to make this year and sort of if you can talk about any sort of broad outlook on that for 23. And just my second question is I believe you have some interest rate hedges in place where you've swapped your fixed rate for floating. So curious if you could share some perspective around what your exposure is to that and sort of when those hedges expire.
spk16: Thank you. Good afternoon, and thank you for the questions. On MA's margin, I'll speak really about 2022. So after expanding MA's adjusted operating margin to be above 30% year-to-date, we obviously are pleased to raise our guidance to approximately 30%, which is up from approximately 29% last quarter. And that includes about 100 basis points of margin compression, from unfavorable foreign exchange translation rates and approximately 30 basis points of net headwinds from recent acquisitions, primarily RMS. And what that really means is that the underlying MA margin is expected to expand by over 500 basis points off of 2021's actual result of 26%. I will note that the 100 basis points improved full-year margin outlook does reflect new and ongoing expense control initiatives, primarily supported through actions from our corporate or shared service areas who are still investing back in the business. And we still expect expenses to increase in support of growth opportunities in MA in the fourth quarter as we capitalize on our existing revenue momentum. On your second question around floating rate exposure, so we seek to maintain a floating rate exposure of between 20% and 50% of our overall debt portfolio. And although we initially issue all debt at a fixed rate, we do maintain a basket of interest rate and cross-currency swaps that convert a portion of outstanding fixed rate exposure to floating rates. So as of September 30th, our floating rate debt was approximately 32% of the portfolio. And then now most importantly, that's apportioned as 28% Euro exposure and just 4% US dollar exposure. So our swap portfolio has performed very well historically. It's reduced annual interest expense by about 55 million in 2021 and an anticipated 40 million this year. And it also brings our weighted average cost of capital down by about 20 basis points to just under 3.1%. If I try to think forward now, about the impact to our P&L from the latest forward curves and what they imply for Euro and US dollar moves, you could think about the swap portfolios moving to a more neutral rather than positive impact. So taking that into account, plus the fact that we issued debt this past August, I would expect the actual interest expense in 2023 to be higher by between $40 and $60 million.
spk09: Yeah, and just to kind of reemphasize, you know, the balance that we're trying to get right is being financially disciplined while at the same time making the investments that we need to make to continue accelerating ARR growth in the MN.
spk01: Great. Thank you so much.
spk03: Your next question is from the line of Craig Huber with Huber Research Partners.
spk15: Please go ahead. Yes, hi, thanks. Two quick housekeeping questions on pricing and incentive compensation costs. Historically, you guys raise prices usually 3% to 4% on average across the portfolio. What's it going to be this year, please? Is it entirely different for the ratings business versus the overall? And then what's your outlook for pricing maybe next year? Maybe it's too early to talk about that, but if you touch on that, I'd appreciate it. And then what was the incentive comp in the third quarter versus what it was the first two quarters? Thank you.
spk09: Hey, Craig, it's Rob. So on pricing, and I'll touch, you know, first of all, as we always say, we're looking for kind of a 3% to 4% annual price increase across all of our business. And I would say that, if anything, and you hear us talk about this all the time, you know, the volatility and uncertainty has really reinforced the importance of what we're doing and the value of what we're doing. In MIS, as we do every year, you know, we conduct a very detailed review of our pricing across sectors and regions. And, you know, based on that work in the coming year, our list prices will probably reflect a bit more of an increase than our historical average. But our actual pricing realization, really, as it always does, is going to depend on issuance mix. You know, where does the issuance actually come from? In MA, we always think about our focus on kind of value-based pricing, and that's why product development and integration of our content is so important. We're looking to integrate new analytics and data sets into our offerings because that allows us to support both price increases but also upgrades and add-ons, and that's why we actually think about those two things. And so we're continuing to see some very good usage and demand for our products. That continues to support the pricing opportunity going forward.
spk16: The third quarter and year to date incentive compensation accrual was approximately $60 million and approximately $180 million, respectively. For the full year of 2022, we're expecting incentive compensation to be approximately $240 million. And that implies, obviously, approximately 60 in the fourth quarter. And that's around 30% lower than the total incentive compensation we accrued for in 2021. And that's primarily driven by a downwardly revised outlook for rated issuance.
spk15: Great. Thank you.
spk03: Your next question is from the line of Andrew Steinerman with J.P. Morgan. Please go ahead.
spk00: Hi, Rob. I'm going to ask you about that trough comment. So if you could just be a little more specific what you meant when you think fourth and third quarter is likely to be a trough for debt issuance, noting that we still have unfavorable mix in the fourth quarter. When would you expect MIS revenue to start to improve?
spk09: Yeah, so what I really meant was the year-over-year quarterly declines in revenue in MIS, we would expect a trough in the third, fourth quarter of this year. So we've got a tough comp in the first quarter of next year from an issuance perspective, but we think that the rate of declines have probably bottomed out here in the third or fourth quarter, and we'll start to see gradual improvement throughout the balance of next year.
spk00: Right. Okay. That's a revenue compliment. I got it. Thank you.
spk03: More next questions from the line of Shlomo Rosenbaum with Stiefel. Please go ahead.
spk05: Hi. Thank you for taking my question. I want to touch on both what Manav talked about and, you know, Tony talked about. With the refi walls that we keep talking about, how much real support is there from these refi walls for MIS revenue? Like if I were to just sit flat out and say, hey, you know, 2022 midpoint of revenue guidance, if we just have our refi walls, You know, that would provide X percent of revenue. You know, is that something you could provide so that we can get some kind of sense on that? And then just on the refi walls, I mean, most of the people on this call are, you know, were on a call earlier this morning that heard, you know, the CFO saying, hey, with the rates going up. we're going to start, you know, paying down more debt. And I'm just trying to understand what, you know, leverage measured as, you know, debt divided by EBITDA doesn't take into account the interest expense. And, you know, CFOs, you know, they want their earnings to increase besides just, you know, looking at debt to EBITDA. And how are you kind of factoring that into your refi wall expectations?
spk09: Yeah, so maybe just to try to come back and triangulate to see if this can help. You know, if you think about the – and this is the first part of your question. If you just think about the – let's talk about in the corporate space. If you think about the maturities that are coming due in 2023, right? So we do our maturity walls. We've got four years of forward maturities. And then when we look at what our expectation is for global corporate finance issuance for this year, and I understand the 2023 maturity walls are going to get refinanced next year, but just given current levels of activity, it's about 50%. So that, I think, is how you can start to size, right? And then you can say, okay, well, now as I think about the way to build to MIS revenue, well, 40% of it roughly is recurring revenue. Then I've got 60% transaction. How much is corporate and how much are those maturity walls there in corporate? Because, you know, that thing tends to be much more stable with financial institutions on kind of more regular issuance calendars and so on. Hopefully that kind of gives you a sense of the size relative to the current activity levels in the market today.
spk16: And just on deleveraging for a second, the dearth of issuance that we've seen, obviously, as a result of the year-to-date cyclical market disruption, doesn't indicate or lead us to believe or expect a trend of deleveraging. Just think about this factor, you know, when estimating future refinancing activities, one factor is certainly rising rates. That's going to deter individual company treasurers from necessarily retiring use, for example, or retiring debt, for example, through the use of any excess cash on the balance sheet. And the rationale we're thinking there is that as the cost of debt increases, companies are going to be more likely to retain debt that was borrowed at more favorable interest rates rather than pay off those borrowings and then incurring the potential risk of being required to reissue in the future at higher rates and therefore potentially lower investor demand.
spk03: We have questions from the line of Russell Quelt with Redburn. Please go ahead.
spk11: Yeah, thanks, Samuel and Nicole. A couple of questions. Firstly, am I right in saying that the ARR for decision solutions has fallen quarter on quarter from 11% previously to 10% this quarter? And if so, why? Maybe start there. Thanks.
spk09: I understand – hello, and thanks for joining the call. I understand how you've drawn that conclusion, but I think there's some nuance here that we need to be able to provide to you. So ARR is an organic number, and it always has been for us. So we have not had RMS in our ARR number that we have been reporting. So decision solutions, ARR grew about – 10% in the quarter, but that's with RMS now included. It was not previously. So that created a three percentage point drag on Decision Solutions ARR. That would have been 13% if we go back to the last quarter, Decision Solutions now on a like-for-like basis, was 11%. So we look at this as actually an acceleration of a like-for-like ARR. And I think everybody on this call knows that, you know, RMS has had a lower growth profile. We're confident about our ability to enhanced that growth profile, but the ARR growth in RMS today is lower than MA, so it has a dilutive effect now that we're including it in the ARR metric. I would say the same thing is true if we zoom out at the MA level, and I think that's important to understand, too. So RMS was about a one percentage point drag on overall MA ARR. So, again, on a like-for-like basis, MA ARR, if we had not included RMS, would have been about 10%, up from 9% last quarter. And as you know, we're guiding to low double-digit for the full year. So, you know, you heard me mention acceleration of ARR. That's why we feel that there's an acceleration of ARR. Okay.
spk11: Yeah, that makes sense. Thanks. And just as a follow-up, I mean, given the experience of 2022, is now the time to look more seriously at scale M&A opportunities in M&A as a way of sort of reducing earnings volatility in the business? And I just wonder what your appetite for deals in this environment would be. Thanks.
spk09: Yeah, so we have a very active approach to corporate development. We always have. We have some very well-defined product roadmaps and what we call business blueprints about, you know, what are our customers looking for across our various, you know, product suites and where do we have gaps. Obviously, we were pretty active last year and over the last several years, and we feel really good about, you know, bringing in RMS and really bulking up our capabilities around insurance and climate. So I think we feel pretty good about the portfolio that we got. Sometimes it's harder to transact in these markets than you think because there's a bid-ask spread between what the sellers think is their valuation and what the buyers are willing to pay. And I would view us, I always have, as a disciplined buyer. We've got to make sure that we can achieve the synergies to make sure that we get the you know, hit the return hurdles that we want. So I guess I would say we're always looking. We're very disciplined in this market. And we've been using this time to really integrate what we've acquired over the last several years and really make sure that we're getting the value out of those acquisitions that we were seeking to get. And, frankly, we feel pretty good about the integration and the progress we're making around a number of those deals that we've done over the last few years.
spk03: Your next question is from the line of Jeff Mueller with Baird. Please go ahead.
spk02: Yeah, thanks for taking the question. Maybe if you could put some additional commentary around enhancing RMS's growth profile. So I caught that it's on track from a financial target perspective. But, for instance, like how are the upgrades to the new platform going? Where are you in terms of integrating the Heritage Moody's capabilities and leveraging MA's gun market? And I guess related to it, you know, I think there's some that think ESG has taken a bit of a hit in 2022. Is that showing through in terms of demand for your ESG solutions from clients and prospects or not? Thank you.
spk09: Yeah, so I'd say I'm pretty encouraged by where we are with RMS. And we've got a number of things that we're making some real progress around integration. We're on track, certainly, for the financial targets that we announced at the time. We're a year in. We have confidence over our ability to continue to accelerate sales and revenue growth next year. You had asked about some of the tangible things that we're doing. um let me just touch on a few so um we've had some really nice traction around uh what we call esg for underwriting and that's taking moody's esg content and then being able to integrate it into the underwriting and portfolio management processes of rms customers and um one of the things that that that that our customers were looking for is just very broad coverage and so That's been – we've made some very good progress there. Second, we've been integrating RMS's life risk models into our existing life offerings. And then on climate, and as you know, when we announced this deal, you know, we wanted to be able to move much more substantively into insurance, but we also wanted to be able to leverage their climate capabilities. And we're developing a pretty thorough product roadmap around what we call climate on demand. And so we've been engaging with a lot of customers in the banking and commercial real estate space about what they need and want around climate, and we're building out that capability, leveraging the RMS IP and models, and we're building a sales pipeline for that. Another area that we see a lot of synergy is around commercial real estate. You know, you've got RMS has a depth of information, obviously, about the physical risk relating to properties. We have an enormous amount of information about a wide range of aspects of any given property in terms of market, location, creditworthiness of tenants, and so on. And so we're pulling all of that together to create what we call kind of a high-definition view of real estate. And we think that that's going to be a very interesting offering for us. I'm only going to touch on ESG very briefly because there's a lot more I could get into. But around ESG, what we're starting to see is that there is more and more demand to be able to translate ESG and climate specifically to financial risk, with the rigor that the market wants and needs. So I kind of think of that as version 2.0 of what the market is looking for. Second, the market needs very broad coverage, and this is where we're having some great conversations with our bank and insurance customers who say, I need to understand the ESG profile of, say, 150,000 companies. Well, we've got coverage on 300 million companies leveraging the Orbis database and our modeling and ESG capabilities. So that is a source of real competitive differentiation for us. And then lastly, there's growing demand for understanding the physical risk related to extreme weather and climate change and transition. And with RMS, we've got that at scale.
spk16: Maybe just two quick numbers around that. So we are maintaining our expectation for 2022 RMS sales growth to be in the mid-single-digit percent range, and that's obviously up from RMS's historical growth rate in the low single-digit percent range. We also now expect RMS to become accretive or moderately accretive to adjusted diluted EPS in 2023. So that's a year earlier than what we previously projected in our deal model and as we communicated previously to the market. And then finally, you know, expectation for ESG and climate-related revenue is for a low double-digit percent growth this year to approximately $119 million.
spk09: Yeah, and maybe the last thing I'd add, kind of beyond the numbers, but this stuff's important, is we just found that the marriage with RMS has been a great cultural fit. And our teams are working really well together, and I think that bodes really well for our ability to kind of deliver on, you know, integrated risk assessment together.
spk02: Got it. Thank you both.
spk03: Your next question is a follow-up from the mind of Alex Cram with UBS. Please go ahead.
spk13: Oh, hey. Thanks. Hello again. I know it's late in the call, but just coming back to my original question from earlier, Mark, your mid-50s comment on MAS was helpful, but I think as somebody else said, there's probably some sort of growth assumption embedded in that. If I may come back to the specifics I asked about earlier, can you give us a little bit more help when it comes to the net impact of the $200 million restructuring this year and next year, and then how we should be thinking about incremental margins in MIS as we think about 2023? I think that would be helpful as we have our own growth assumptions, clearly.
spk16: Alex, I appreciate you coming back into the queue to ask this question. We would like to intentionally not front-run our MIS revenue outlook for 2023. I think what we are comfortable committing to as a management team is what we're able to control, and we certainly are able to control our expense base. And I think what we're also comfortable to commit to you is that we'll get the 2023 MIS adjusted operating margin at least in that mid 50s percentage range in other words as you consider modeling this out we don't want you to take the approximately 51 that we're guiding to for 2022 and assume that's a new baseline yeah and i guess alex um i i would say uh you know we we don't want to base that on just hoping that there's growth in order to get to that level so we um uh the hope is not a strategy so we we've really tried to think about the expense base
spk09: without having to think that the only way that we can get to that margin that Mark is talking about is by having a huge snapback in revenue. Hopefully that gives you a little bit of insight.
spk13: No, I appreciate it very much. Thank you.
spk03: Going next, a question. There's a follow-up from the line of Manav Patnaik with Barclays. Please go ahead.
spk14: Yeah, sorry. Maybe I can just follow up to that question. So the $200 million savings, is that all? in the MIS business? Is that how you get to the next 50 years? And I guess, you know, any kind of margin commitment for MIS in this regard?
spk16: The $200 million or at least $200 million in run rate savings of our 2023 expense base will benefit both MIS and MA. As you can anticipate or you could probably infer, the benefit to MIS may be larger than the benefit to MA, given how we're targeting expenses with being very deliberate and very thoughtful around how we manage the expense base for the two businesses, as well as the allocation of corporate expenses. On the MA adjusted margin, as we think about it, I think the way I'd propose to think about this is through a medium term lens here. And there I would say that we remain on track to achieve our medium-term adjusted operating margin for MA of a mid-30% range within that three to five years. And that's primarily due to, as you heard on this call, an increase in the proportion of prescription-based product sales. They provide improved operating leverage, especially as recurring revenue becomes an increase in proportion of MA's total revenue base.
spk14: Okay, thank you.
spk03: Your next question is a follow-up from the line of Kevin McVeigh with Credit Suisse. Please go ahead.
spk18: Great. Thanks so much. Hey, there's been a lot of questions on corporate issuance, but I wonder, Mark, if you could talk about your own debt. It seems a little high. Anything to kind of call out there? Is it timing? Maybe you could just frame that for us a little bit.
spk16: Kevin, thanks very much for the question. So we remain committed to anchoring our financial leverage around the BBB rating, which we believe provides the appropriate balance between ensuring ongoing financial flexibility and lowering the cost of capital. And, you know, capital management really does extend beyond prudent allocation. We are thoughtful about our leverage and liquidity levels. as well as maintaining a strong balance sheet. And over the last two years, we've enhanced our capital position and reduced our cost of capital, both by structuring a well-ladded debt maturity schedule and by extending our debt maturity profile to take advantage of, at the time, what is a relatively flat yield curve and historically low rates. Although our net debt to adjusted operating income, and I think this is the point that you're getting at, was 2.3 times as of september 30th and that's well within the triple v plus rating range when accounting for our cash position we have seen an uptick in our gross debt to adjusted operating income range which is approximately 2.9 times as of september 30th but that's a direct result of a significantly weakened global economic conditions again relative to our first and second quarter outlooks of perhaps executing a very small or very limited debt repurchase strategy in the coming months, just allowing us to opportunistically take advantage of current market conditions to marginally, marginally, marginally deliver our balance sheet and improve our gross debt position.
spk18: That's helpful. And then I know it's getting late, but Mark, just any comments on CapEx for the balance of the year?
spk16: Absolutely, Ian. We expect CapEx for full year 2022 to be approximately $300 million. As a reminder, there are a number of factors underpinning our CapEx guidance, including our strategic shift to developing SaaS-based solutions for our customers, continued acquisition, integration activities specifically around our recent KYC and RMS acquisitions, as well as ongoing enhancements to our office and IT infrastructure associated with some of our Workplace of the Future programs. You know, we're not providing guidance for 2023. However, we do currently foresee absolute dollar capex to remain at similar levels to 2022, especially as we continue to emphasize developing hosted solutions.
spk03: Very helpful. Your next question is a follow-up from the line of Craig Huber with Huber Research Partners. Please go ahead.
spk15: Yes, hi. Mark, can you just dig in a little bit further on your 2022 expense bridge attribution and also curious what's your currency sensitivity right now in costs? Thank you.
spk16: On the 2022 expense outlook, we are lowering our full-year 2022 operating expense guidance from growth in the high single-digit percent range to the upper end of the mid-single-digit percent range. And Outlook for the year assumes additional expense accruals in the fourth quarter of up to $55 million related to the expanded restructuring program that we've spoken about. If I were to exclude these restructuring-related charges, our outlook for the full-year operating expenses would have been at the lower end of the mid-single-digit percent growth range. And that's just demonstrating the ongoing expense discipline and prudence, especially compared to our full-year guide back in February, which was for an increase in the low double-digit range for expenses at that time. Specifically to your question, Craig, for the full-year 2022, we anticipate expense growth of approximately seven percentage points related to acquisitions completed in the last 12 months it's primarily rms approximately three percentage points related to their structuring program and then ongoing growth and investments net of cost efficiencies and lower incentive compensation is approximately flat and then there's a small partial offset from favorable movements in foreign exchange rates of approximately four percentage points. And that should get you to that answer. On your second question, just on FX, we have seen significant moves this quarter in FX. And so if I were to update the annualized impacts of further foreign currency movements for modeling purposes, they would be every one cent movement between the U.S. dollar and the euro will impact full-year EPS by approximately three cents. and then full year revenue by approximately $10 million. And then every one cent FX movement between the dollar and the pound impacts full year revenue by approximately $2 million, and then full year operating expenses by $2 million. So call that effectively neutral on an EPS basis.
spk15: Great. Thank you.
spk03: Your next question is a follow-up from the line of Owen Lau with Oppenheimer. Please go ahead.
spk19: Thank you for squeezing me in. Could you please talk about Is there any impact from the Inflation Reduction Act on your share repurchases program? Thank you.
spk08: I don't think we expect any material impact, tax impact, at least, on share repo.
spk19: Okay. Thank you very much.
spk03: Your next question is a follow-up from the line of Shlomo Rosenbaum with CFO. Please go ahead.
spk05: Hi, thank you for squeezing me back in. Hey, Rob, the MA revenue has been remarkably resilient. I was just wondering, is there any areas within there that you would think if we head into like a real, you know, significant recession that we would start to see some kind of changes in the growth rates over there? Like, how should we think about that on a component basis?
spk09: Yeah, Shlomo, great question. you know i mentioned in the opening remarks that you know it's been pretty acyclical and uh you know, I know it might sound trite, but it is because they're providing, you know, these mission-critical products that are helping organizations deal with risk. So in times of stress, the value prop of our offerings actually increases. And, you know, we see that with things like our credit view usage that's up, you know, on a year-over-year basis. And, you know, I have to say, I've been meeting with a lot of customers, and, you know, you know this strategy to help customers with this multi-dimensional and integrated perspective on risk it really does resonate and i think it resonates more now than ever we're having some really great conversations with our customers um so we feel good about that um you know if you think about like a severe downturn um you know let's take the global financial crisis um in that case uh you know what we saw was that we had some uh some bankruptcies we had you know some consolidations In certain sectors, you know, the banking sector obviously was under, you know, pretty severe stress. And at the time, you know, a much bigger proportion of MA's customer base was banking. So, you know, we were more exposed to the banking sector at that time. And we did see, you know, that we, you know, retention rates would tick down a little bit, you know, as we lose customers. You know, and we've talked about on the calls before, our retention rates are pretty high right now. But we could also see some lengthening of sales cycles. I think others would see the same kinds of things, more challenging pricing discussions, which is why, back to that point I made around pricing, it's so important to be thinking about what is the value that you're driving into the products to be able to support pricing. It's really important to be able to communicate that to your customers in times like this. But I guess the last thing I'd say, Shlomo, is it's a pretty challenging environment right now, and not only are we not seeing that, but as I said earlier, we're actually accelerating ARR growth in the current environment.
spk05: Okay, great.
spk03: And at this time, there are no further questions. Please continue with any closing remarks.
spk09: Okay, with that, thank you, everybody, for joining. I appreciate the questions, and we'll talk to you on the next earnings call. Have a good day.
spk03: This concludes Moody's third quarter 2022 earnings call. As a reminder, immediately following this call, the company will post the MIS revenue breakdown under the investor resources section of the Moody's IR homepage. Additionally, a replay will be made available immediately after the call on the Moody's IR website. Thank you.
Disclaimer